Alberto García-Salido

Dr. Alberto García-Salido

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2020 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
MCMarta Cabrero-Hernández
Marta Cabrero-Hernández
AGAlberto García-Salido
Alberto García-Salido
ILInés Leoz-Gordillo
Inés Leoz-Gordillo
JAJose Antonio Alonso-Cadenas
Jose Antonio Alonso-Cadenas
AGAinhoa Gochi-Valdovinos
Ainhoa Gochi-Valdovinos
ASAna Serrano-González
Ana Serrano-González
We describe 5 children with severe SARS-CoV-2 infection, hemodynamic instability and suspected acute abdomen. This form of the disease has not been previously documented. Four of the cases were confirmed SARS-CoV-2 infection and 1 probable. All of them were previously healthy and needed a pediatric critical care unit admission. The respiratory symptoms were not dominant or were absent. Also, fever was observed. Laboratory testing revealed lymphopenia and high levels of C-reactive protein and procalcitonin with d-dimer, ferritin and interleukin-6 usually elevated. Respiratory support and inotropic support were almost always necessary. In all of them, deterioration occurred on the day of admission.

1 August 2012 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
GOGonzalo Oñoro
Gonzalo Oñoro
AGAlberto García-Salido
Alberto García-Salido
IMIgnacio Mastro Martínez
Ignacio Mastro Martínez
BCBeatriz Cabeza
Beatriz Cabeza
MGMaría Gillén
María Gillén
AAAmelia Martínez de Azagra
Amelia Martínez de Azagra
When pertussis is associated with hyperleukocytosis, mortality approaches to 80%. Immature leukocytes have been identified in pulmonary arterioles, small arteries and venules. Techniques aimed at reducing leukocyte mass might improve the prognosis of these patients. We report our experience with 3 patients in whom a leukoreduction was performed in the context of severe pertussis and hyperleukocytosis.

17 June 2019 in Paediatrics & Child Health
Verified
Journal Article
Closed access
PDF file
MRMarta Velasco Rodríguez-Belvís
Marta Velasco Rodríguez-Belvís
JBJavier Francisco Viada Bris
Javier Francisco Viada Bris
CFCarmen Plata Fernández
Carmen Plata Fernández
AGAlberto García-Salido
Alberto García-Salido
JAJulia Asensio Antón
Julia Asensio Antón
RCRosa Ana Muñoz Codoceo
Rosa Ana Muñoz Codoceo
Background/Objectives: The paediatric reference range of fecal calprotectin (FC) has not been decisively established and previous studies show a wide within-age variability, suggesting that other factors like anthropometric data or type of feeding can influence FC. Our aims were to establish the normal levels of FC in healthy children grouped by age and analyze whether sex, gestational age, birth weight, type of delivery, type of feeding, or anthropometric data influence FC values.Methods: This multicentre, cross-sectional, and observational study enrolled healthy donors under 18 years of age who attended their Primary Health Care Centre for their routine Healthy Child Program visits. The exclusion criteria were: (i) immunodeficiency, (ii) autoimmune or (iii) gastrointestinal disease; (iv) medication usage; (v) gastrointestinal symptoms; or (vi) positive finding in the microbiological study.Results: We enrolled 395 subjects, mean age was 4.2 years (range 3 days to 16.9 years), and 204 were male. The median FC was 77.0 mcg/g (interquartile range 246). A negative correlation between age and FC was observed (Spearman’s rho = −0.603, P<0.01), and none of the other factors analyzed were found to influence FC levels.Conclusions: Normal FC values in healthy children (particularly in infants) are higher than those considered to be altered in adults and show a negative correlation with age. It is necessary to reconsider the upper limits of FC levels for paediatric patients according to age, with further studies required to determine other factors that influence FC during infancy.

1 February 2021 in Anales de Pediatría
Verified
Journal Article
Open access
AGAlberto García-Salido
Alberto García-Salido
JAJordi Antón
Jordi Antón
JMJosé David Martínez-Pajares
José David Martínez-Pajares
GGGemma Giralt Garcia
Gemma Giralt Garcia
BCBorja Gómez Cortés
Borja Gómez Cortés
EPEnrique Villalobos Pinto
Enrique Villalobos Pinto
Se ha descrito un nuevo síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2. Este cuadro presenta una expresividad clínica variable y se asocia a infección activa o reciente por SARS-CoV-2. En este documento se revisa la literatura existente por parte de un grupo multidisciplinar de especialistas pediátricos. Posteriormente, se realizan recomendaciones sobre estabilización, diagnóstico y tratamiento de este síndrome.

21 October 2022 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Open access
Danilo BuonsensoDanilo Buonsenso
Danilo Buonsenso
APAida Msc Perramon
Aida Msc Perramon
MCMartí Català
Martí Català
JTJuan Pablo Torres
Juan Pablo Torres
CGCamacho-Moreno Germán
Camacho-Moreno Germán
ASAntoni Soriano-Arandes
Antoni Soriano-Arandes
Background: SARS-CoV-2 variations as well as immune protection after previous infections and/or vaccination may have altered the incidence of multisystemic inflammatory syndrome in children (MIS-C). We aimed to report an international time-series analysis of the incidence of MIS-C to determine if there was a shift in the regions or countries included into the study. Methods: This is a multicenter, international, cross-sectional study. We collected the MIS-C incidence from the participant regions and countries for the period July 2020 to November 2021. We assessed the ratio between MIS-C cases and COVID-19 pediatric cases in children <18 years diagnosed 4 weeks earlier (average time for the temporal association observed in this disease) for the study period. We performed a binomial regression analysis for 8 participating sites [Bogotá (Colombia), Chile, Costa Rica, Lazio (Italy), Mexico DF, Panama, The Netherlands and Catalonia (Spain)]. Results: We included 904 cases of MIS-C, among a reference population of 17,906,432 children. We estimated a global significant decrease trend ratio in MIS-C cases/COVID-19 diagnosed cases in the previous month (P < 0.001). When analyzing separately each of the sites, Chile and The Netherlands maintained a significant decrease trend (P < 0.001), but this ratio was not statistically significant for the rest of sites. Conclusions: To our knowledge, this is the first international study describing a global reduction in the trend of the MIS-C incidence during the pandemic. COVID-19 vaccination and other factors possibly linked to the virus itself and/or community transmission may have played a role in preventing new MIS-C cases.

1 January 2019 in Emerging Infectious Diseases
Verified
Journal Article
Open access
Carmen Niño-TaravillaCarmen Niño-Taravilla
Carmen Niño-Taravilla
IPIsabel Pérez-Sebastián
Isabel Pérez-Sebastián
AGAlberto García-Salido
Alberto García-Salido
CSClaudia Varela Serrano
Claudia Varela Serrano
VEVerónica Cantarín Extremera
Verónica Cantarín Extremera
AGAna Serrano González
Ana Serrano González
Among 30 patients, the most frequently isolated enterovirus serotype was A71.